Maplelane Capital’s Argan AGX Stock Holding History

Maplelane Capital’s Portfolio AGX Stock Details AGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-60,000	Closed	-$16.2M	–	77
2025 Q3	$16.2M	Buy	+60,000	New	+$13.7M	0.39%	64

Other funds holding AGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Maplelane Capital's AGX Position: Q4 2025 in Review

Maplelane Capital sold out of Argan (AGX) in Q4 2025, closing a stake of 26,000 shares — an estimated $7.02M sold.

Maplelane Capital first reported a position in AGX in Q3 2025 and held it in 1 quarter. The position peaked at $7.02M in Q3 2025. 432 funds tracked by Wall St. Rank hold AGX as of Q4 2025.

Maplelane Capital reported no remaining Argan position as of Q4 2025 after selling out during the quarter.
Maplelane Capital sold 26,000 Argan shares in Q4 2025, an estimated $7.02M.
Maplelane Capital first reported a position in Argan in Q3 2025 and held it in 1 quarter.
Maplelane Capital's Argan position peaked at $7.02M in Q3 2025.
432 funds tracked by Wall St. Rank held Argan as of Q4 2025.

Based on Maplelane Capital's 13F filing for Q4 2025, filed 13 Feb 2026.